Tivoxavir marboxil advancing towards a human influenza challenge trial as a once-monthly prophylactic agent, building on broad preclinical ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SAN FRANCISCO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (VIR) today announced it has achieved the target enrollment of approximately 3,000 participants in the groundbreaking Phase 2 ...
Dr. Costa addresses the primary clinician concern regarding BCMA-directed T-cell engagers: infection risk. Early trials ...
– Announcement follows recent U.S. government award from the Biomedical Advanced Research and Development Authority supporting development of VIR-2482 – SAN FRANCISCO, Oct. 18, 2022 (GLOBE NEWSWIRE) - ...
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial This randomized phase II/III trial enrolled patients with SCLC, no brain ...
Gene therapy for hemophilia B allowed almost three-fourths of patients to discontinue prophylactic factor IX therapy with no increase in bleeding, results of the pivotal BENEGENE-2 trial showed. The ...
Tarsus Pharmaceuticals recently dosed the first participant in its Phase 2 Calliope trial of TP-05, an investigational oral therapy aimed at preventing Lyme disease in approximately 700 at-risk adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results